Pan Cancer T BV of the Netherlands, a developer of T cell receptor (TCR) T cell therapies for cancer, has appointed Chiara Bonini to its scientific advisory board. Dr Bonini is professor of haematology at the University Vita Salute San Raffaele School of Medicine in Italy. Her main research focus is the development of cell and gene therapy approaches for cancer. She pioneered the clinical use of genetically engineered lymphocytes in the context of stem cell transplantation.
Pan Cancer T announced the appointment on 23 February 2023.
Copyright 2023 Evernow Publishing Ltd